We are live on ! Find out more
TCM

Trybe Capital Management Portfolio holdings

AUM $1.09B
1-Year Est. Return 249.75%
This Fund
S&P 500
This Quarter Est. Return
-3.5%
1 Year Est. Return
+249.75%
3 Year Est. Return
+680.91%
5 Year Est. Return
+833.26%
10 Year Est. Return
AUM
$104M
AUM Growth
-$43.3M
Cap. Flow
-$38.7M
Cap. Flow %
-37.2%
Top 10 Hldgs %
100%
Holding
13
New
1
Increased
Reduced
9
Closed
3

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
DNA icon
Ginkgo Bioworks
DNA
+$3.29M
2
AAPL icon
Apple
AAPL
+$1.88M
3
NVDA icon
NVIDIA
NVDA
+$791K
4
NOW icon
ServiceNow
NOW
+$667K
5
MSFT icon
Microsoft
MSFT
+$647K

Sector Composition

Rank Sector Weight
1 Technology 59.24%
2 Communication Services 14.28%
3 Consumer Discretionary 8.37%
4 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
CALL
NVIDIA
NVDA
$5.25T
$18.9M 18.12%
+1,290,000
New +$18.9M
MSFT icon
2
Microsoft
MSFT
$3.57T
$13.2M 12.71%
55,144
-2,694
-5% -$647K
AAPL icon
3
Apple
AAPL
$4.54T
$12.9M 12.44%
99,615
-13,160
-12% -$1.88M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.17T
$11.4M 10.98%
129,452
-6,336
-5% -$602K
NVDA icon
5
NVIDIA
NVDA
$5.25T
$11.4M 10.96%
780,680
-53,920
-6% -$791K
NOW icon
6
ServiceNow
NOW
$134B
$10.5M 10.12%
135,640
-8,530
-6% -$667K
AMZN icon
7
Amazon
AMZN
$2.81T
$8.71M 8.37%
103,705
-5,547
-5% -$548K
CRM icon
8
Salesforce
CRM
$168B
$7.81M 7.5%
58,893
-4,265
-7% -$622K
MRVL icon
9
Marvell Technology
MRVL
$225B
$5.72M 5.5%
154,475
-15,827
-9% -$646K
RBLX icon
10
Roblox
RBLX
$27.6B
$3.43M 3.3%
120,648
-17,513
-13% -$615K
DNA icon
11
Ginkgo Bioworks
DNA
$469M
-26,359
Closed -$3.29M
NEM icon
12
CALL
Newmont
NEM
$134B
-955,300
Closed -$40.2M
RBLX icon
13
CALL
Roblox
RBLX
$27.6B
-200,000
Closed -$7.17M

Similar funds

Trybe Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Trybe Capital Management held 13 positions worth $104M, down 29% from $147M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trybe Capital Management withdrew a net $38.7M in Q4 2022, closing 3 positions and reducing 9 holdings. Its most notable exit was Ginkgo Bioworks, an estimated $3.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 59% of assets, up from 45% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Trybe Capital Management's biggest Q4 2022 reduction was Apple, cutting an estimated $1.88M.
  • Trybe Capital Management fully exited Ginkgo Bioworks in Q4 2022, selling an estimated $3.29M.
  • Trybe Capital Management's ten largest holdings make up 100% of its $104M portfolio in Q4 2022.
  • Trybe Capital Management opened 1 new position and closed 3 in Q4 2022.
  • Trybe Capital Management's portfolio value fell 29% quarter-over-quarter to $104M.

Based on Trybe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.